Abstract: The invention relates to an implantation device (10a-d) comprising at least one medical implant (12a-d) and at least one implantation aid (14a-d) comprising at least one expansion element (16a-d). It is provided that the expansion element (16a-d) can be inserted into at least one cavity (18a-d) of the implant (12a-d), and the at least one cavity (18a-d) can be expanded using the expansion element (16a-d), and, in the end state, the expansion element (16a-d) is disposed at least partially in the at least one cavity (18a-d), wherein the expansion element (16a-d) is designed as a solid body (20a-d).

Abstract: The invention relates to a medical valve implant (10a-d), in particular a heart valve implant (12a-d), for implantation in an animal body and/or human body, comprising a support frame (14a-d) which has at least one wall (16a-d). It is provided that one region (18a-d) of the at least one wall (16a-d) of the support frame (14a-d) is curable.

Abstract: The invention relates to an implant comprising an active-agent-containing coating which covers the implant at least in sections. The coating is composed of at least two subsections; a first subsection contains the at least one active substance, and a second subsection contains an auxiliary agent.

Abstract: The present invention refers to an implant with a surface layer having a topographic modification. The topographic modification includes a line pattern with ridge and groove widths of 0.9 to 1.1 ?m and a ridge height of more than 0.9 ?m.

Abstract: A method for producing an implant, particularly an intralumimal endoprosthesis, having a body, wherein the body comprises magnesium or a magnesium alloy. In order to control the degradation in a desired time window, such as between four weeks and six months, the following production method is carried out: a) preparing the implant body, b) applying a metallic coating onto at least a portion of the body surface, the primary constituent of the coating being at least one element of the group containing titanium and aluminum, c) plasmachemical treatment of the portion of the body surface provided with the coating in an aqueous solution in order to produce a layer created by plasmachemical treatment by applying a mixed voltage generating the plasma to the body of the implant, wherein the mixed voltage has sufficient energy to temporarily ionize both the metallic coating and a subjacent region of the implant body. The invention further relates to an implant that can be obtained by such a method.

Abstract: One embodiment of the invention relates to a biocorrodible implant based on magnesium or a biocorrodible magnesium alloy, whose surface has a corrosion-inhibiting coating. Furthermore, other invention embodiments relate to a respective manufacturing method for the coating.

Abstract: The invention relates to an implant of a biocorrodible metallic material with a passivating coating of a nanoparticle-containing silane coating and an associated method for producing the implant.

Abstract: A stent having a structure made of a biocorrodible metallic material, having multiple web sections connected to one another, with a support structure made of a number of first web sections connected to one another, designed to assume a function supporting the vascular wall or preserving the mechanical integrity of the stent for a predefinable time after expansion; and at least one second web section electrically connected directly to a first web section of the support structure, which does not assume a function supporting the vascular wall or preserving the mechanical integrity of the stent for the predefined time after the expansion, and whose electrode potential E2 is reduced by a mechanical strain of the second web section during or before the expansion so it is lower than an electrode potential E1 of the first web section after the expansion.

Abstract: An implant made of a biocorrodible metallic material having a coating made of an organosilicon compound.

Abstract: A method of applying a marker element (6; 6?; 6?; 25; 25?; 26; 28) to an implant (1; 1?; 1?; 1??; 20; 20?), in particular a stent, intended for implantation in the human or animal body, comprising a main body and an opening (3; 3?; 3?; 3??; 21; 21?) provided in said main body (2; 2?; 2?; 2??; 22; 22?) for receiving the marker element (6; 6?; 6?; 25; 25?; 26; 28), wherein to form at least a part of the marker element (6; 6?; 6?; 25; 25?; 26; 28) a hardenable material or material mix is introduced into the opening and hardened therein.

Abstract: A method of applying a marker element (6; 6′; 6″; 25; 25′; 26; 28) to an implant (1; 1′; 1″; 1′″; 20; 20′), in particular a stent, intended for implantation in the human or animal body, comprising a main body and an opening (3; 3′; 3″; 3′″; 21; 21′) provided in said main body (2; 2′; 2″; 2′″; 22; 22′) for receiving the marker element (6; 6′; 6″; 25; 25′; 26; 28), wherein to form at least a part of the marker element (6; 6′; 6″; 25; 25′; 26; 28) a hardenable material or material mix is introduced into the opening and hardened therein.